The most recent addition to the Biovitals® platform, Hospital@HomeTM, is an end-to-end solution that enables hospitals and health systems to quickly deploy a home hospital program that delivers inpatient-level care within patients' homes. It includes clinical care services and non-clinical services such as program management, operations, supply chain and revenue cycle management. In late 2020, the Centers for Medicare and Medicaid Services (CMS) announced reimbursement parity with inpatient care for hospitals with such "hospital at home" programs. Biofourmis originally co-developed Biovitals® Hospital@Home™ with Brigham and Women's Hospital, a Harvard teaching hospital, for use in Brigham's Home Hospital Program.
"Our vision is to become the most comprehensive and tightly integrated care-at-home platform across a range of patient acuity levels and medical conditions," Dr. Majmudar said. "As we expand our offerings to including in-home provider services, we will continue to demonstrate the value of our solution through improved outcomes that support both providers and insurers in value-based care arrangements that include shared risk."
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
He added: "I look forward to helping accelerate Biofourmis' product roadmap and commercial growth to become the most sought-after care-at-home platform for health systems, payers and newer value-based primary and specialty care companies."
Former Mentor Turned Advisor
Dr. Majmudar's history with Biofourmis founder and CEO Kuldeep Singh Rajput pre-dates the company to 2014 when Rajput was an undergraduate student in India participating in the Massachusetts Institute of Technology (MIT) Media Lab's REDX program, a workshop focused on developing affordable medical diagnostics. Dr. Majmudar was a clinical advisor for the program and worked with Rajput on multiple cardiovascular diagnostic devices. The experience helped shape Rajput's thinking around unmet patient and provider needs and the opportunities to apply technology and data science in medicine.
A short time later, when Rajput was a PhD student in neuroscience at the National University of Singapore, he sought Dr. Majmudar's guidance about whether to drop out of the doctoral program to launch Biofourmis. Rajput eventually left the program, following his passion and founding Biofourmis in November 2015. Dr. Majmudar continued to serve as a mentor to Rajput, ultimately becoming a clinical advisor to Biofourmis and then a member of the board before his recent appointment to chief medical officer.